SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5t0h'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HO5_A_ADNA1604_1
(5'-NUCLEOTIDASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 11 GLY f 203
PHE f 217
GLY f 200
PHE f 221
ASP f 234
 None
 1.09A 1ho5A-5t0hf:
undetectable		 1ho5A-5t0hf:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HO5_B_ADNB2604_1
(5'-NUCLEOTIDASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 10 GLY f 203
PHE f 217
GLY f 200
PHE f 221
ASP f 234
 None
 1.10A 1ho5B-5t0hf:
undetectable		 1ho5B-5t0hf:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IKE_A_HSMA190_1
(NITROPHORIN 4)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		3 / 3 ASP f 262
LEU f 255
LEU f 259
 None
 0.69A 1ikeA-5t0hf:
undetectable		 1ikeA-5t0hf:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RLB_F_REAF177_1
(RETINOL BINDING
PROTEIN)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 11 PHE f 601
ALA f 536
ALA f 569
LEU f 589
MET f 570
 None
 1.15A 1rlbF-5t0hf:
undetectable		 1rlbF-5t0hf:
11.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_A_THHA3001_1
(AMINOMETHYLTRANSFERA
SE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		3 / 3 ASP f 393
GLU f 468
TYR f 441
 None
 0.86A 1wsvA-5t0hf:
undetectable		 1wsvA-5t0hf:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_A_SAMA301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		3 / 3 LYS f 230
ASP f 188
ASP f 179
 None
 1.10A 2br4A-5t0hf:
undetectable		 2br4A-5t0hf:
15.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_H_BO2H1400_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
 None
 0.80A 2f16H-5t0hO:
29.7
2f16I-5t0hO:
26.2		 2f16H-5t0hO:
55.79
2f16I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F16_V_BO2V1401_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
 None
 0.81A 2f16V-5t0hO:
29.7
2f16W-5t0hO:
26.2		 2f16V-5t0hO:
55.79
2f16W-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNH_A_9CRA501_1
(CYTOCHROME P450 2C8)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 11 SER f 277
ILE f 650
THR f 616
VAL f 296
ILE f 270
 None
 1.13A 2nnhA-5t0hf:
undetectable		 2nnhA-5t0hf:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		4 / 4 LEU f 342
GLN f 381
THR f 378
THR f 359
 None
 1.47A 2zj0D-5t0hf:
undetectable		 2zj0D-5t0hf:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AQI_B_CHDB6_0
(FERROCHELATASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 12 LEU f 341
LEU f 326
ILE f 379
SER f 322
VAL f 311
 None
 1.34A 3aqiB-5t0hf:
undetectable		 3aqiB-5t0hf:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CJT_K_SAMK302_0
(RIBOSOMAL PROTEIN
L11
METHYLTRANSFERASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 12 GLY f 402
VAL f 375
ASN f 406
LEU f 405
LEU f 671
 None
 1.49A 3cjtK-5t0hf:
undetectable		 3cjtK-5t0hf:
16.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_B_TRPB1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		4 / 8 GLY O   5
VAL O 155
ILE O   3
VAL O  99
 None
 0.80A 3fi0B-5t0hO:
undetectable		 3fi0B-5t0hO:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3H52_B_486B1_2
(GLUCOCORTICOID
RECEPTOR)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 12 GLY f 201
GLY f 200
GLN f 205
MET f 162
ILE f 189
 None
 1.20A 3h52B-5t0hf:
undetectable		 3h52B-5t0hf:
15.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_H_BO2H1400_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
 None
 0.82A 3mg0H-5t0hO:
28.6
3mg0I-5t0hO:
26.2		 3mg0H-5t0hO:
55.79
3mg0I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_H_BO2H1400_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O  55
GLN O  57
ALA O  46
GLY O  45
ALA O  49
 None
 1.17A 3mg0H-5t0hO:
28.6
3mg0I-5t0hO:
26.2		 3mg0H-5t0hO:
55.79
3mg0I-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 ALA O  20
ALA O  46
GLY O  47
ALA O  49
SER O 129
 None
 0.77A 3mg0K-5t0hO:
27.1
3mg0L-5t0hO:
24.3		 3mg0K-5t0hO:
28.69
3mg0L-5t0hO:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 ALA O  20
LYS O  33
ALA O  46
GLY O  47
ALA O  49
 None
 0.88A 3mg0K-5t0hO:
27.1
3mg0L-5t0hO:
24.3		 3mg0K-5t0hO:
28.69
3mg0L-5t0hO:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
ALA O  49
 None
 0.89A 3mg0K-5t0hO:
27.1
3mg0L-5t0hO:
24.3		 3mg0K-5t0hO:
28.69
3mg0L-5t0hO:
23.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MG0_V_BO2V1401_1
(PROTEASOME COMPONENT
PUP1
PROTEASOME COMPONENT
PUP3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
 None
 0.84A 3mg0V-5t0hO:
29.7
3mg0W-5t0hO:
26.2		 3mg0V-5t0hO:
55.79
3mg0W-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_Y_BO2Y1403_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 ALA O  20
ALA O  46
GLY O  47
ALA O  49
SER O 129
 None
 0.80A 3mg0Y-5t0hO:
15.7
3mg0Z-5t0hO:
24.0		 3mg0Y-5t0hO:
28.69
3mg0Z-5t0hO:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_Y_BO2Y1403_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
ALA O  46
GLY O  47
ALA O  49
 None
 0.88A 3mg0Y-5t0hO:
15.7
3mg0Z-5t0hO:
24.0		 3mg0Y-5t0hO:
28.69
3mg0Z-5t0hO:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		4 / 7 TYR O 189
VAL O  99
VAL O  13
ILE O  34
 None
 1.14A 3ms9B-5t0hO:
undetectable		 3ms9B-5t0hO:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		4 / 7 TYR O 189
VAL O  99
VAL O 177
ILE O  34
 None
 1.24A 3ms9B-5t0hO:
undetectable		 3ms9B-5t0hO:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUV_B_ASDB126_1
(STEROID
DELTA-ISOMERASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 10 TYR f 622
SER f 276
LEU f 274
ASN f 649
MET f 629
 None
 1.45A 3nuvB-5t0hf:
undetectable		 3nuvB-5t0hf:
10.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S45_B_478B201_2
(PROTEASE)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 GLY O   5
ALA O   4
ILE O  34
ILE O 173
ILE O 159
 None
 0.85A 3s45B-5t0hO:
undetectable		 3s45B-5t0hO:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3THR_D_C2FD1200_0
(GLYCINE
N-METHYLTRANSFERASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 12 LEU f 582
MET f 585
SER f 539
LEU f 609
THR f 577
 None
 1.27A 3thrA-5t0hf:
undetectable
3thrB-5t0hf:
undetectable
3thrC-5t0hf:
undetectable
3thrD-5t0hf:
undetectable		 3thrA-5t0hf:
16.64
3thrB-5t0hf:
16.64
3thrC-5t0hf:
16.64
3thrD-5t0hf:
16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H2F_A_ADNA601_1
(5'-NUCLEOTIDASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 9 GLY f 203
PHE f 217
GLY f 200
PHE f 221
ASP f 234
 None
 1.08A 4h2fA-5t0hf:
undetectable		 4h2fA-5t0hf:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4H2G_A_ADNA603_1
(5'-NUCLEOTIDASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 9 GLY f 203
PHE f 217
GLY f 200
PHE f 221
ASP f 234
 None
 1.13A 4h2gA-5t0hf:
undetectable		 4h2gA-5t0hf:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KMM_B_CHDB503_0
(FERROCHELATASE,
MITOCHONDRIAL)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		4 / 5 MET f  57
ARG f  22
PRO f  84
SER f  87
 None
 1.26A 4kmmB-5t0hf:
undetectable		 4kmmB-5t0hf:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1Z_A_MXMA807_2
(PROSTAGLANDIN G/H
SYNTHASE 1)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		4 / 6 LEU f 231
LEU f 255
PHE f 324
MET f 365
 None
 1.10A 4o1zA-5t0hf:
0.7		 4o1zA-5t0hf:
21.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVL_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 4qvlV-5t0hO:
29.9
4qvlb-5t0hO:
27.6		 4qvlV-5t0hO:
56.17
4qvlb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVL_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 9 THR O   1
LYS O  33
ALA O  46
ALA O  49
THR O  52
 None
 1.03A 4qvlH-5t0hO:
28.7
4qvlI-5t0hO:
26.2		 4qvlH-5t0hO:
56.17
4qvlI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVL_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 4qvlH-5t0hO:
28.7
4qvlN-5t0hO:
27.6		 4qvlH-5t0hO:
56.17
4qvlN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVL_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 0.98A 4qvlV-5t0hO:
29.9
4qvlW-5t0hO:
26.2		 4qvlV-5t0hO:
56.17
4qvlW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVM_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qvmV-5t0hO:
30.1
4qvmb-5t0hO:
27.7		 4qvmV-5t0hO:
56.17
4qvmb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVM_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
CYH O  31
LYS O  33
THR O  48
ALA O  49
THR O  52
 None
 1.05A 4qvmH-5t0hO:
28.9
4qvmI-5t0hO:
26.2		 4qvmH-5t0hO:
56.17
4qvmI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVM_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qvmH-5t0hO:
28.9
4qvmN-5t0hO:
27.7		 4qvmH-5t0hO:
56.17
4qvmN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVM_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
CYH O  31
LYS O  33
THR O  48
ALA O  49
THR O  52
 None
 1.05A 4qvmV-5t0hO:
30.1
4qvmW-5t0hO:
26.2		 4qvmV-5t0hO:
56.17
4qvmW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVN_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 4qvnV-5t0hO:
29.8
4qvnb-5t0hO:
27.5		 4qvnV-5t0hO:
56.17
4qvnb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 1.00A 4qvnH-5t0hO:
28.6
4qvnI-5t0hO:
26.3		 4qvnH-5t0hO:
56.17
4qvnI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVN_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 4qvnH-5t0hO:
28.6
4qvnN-5t0hO:
27.5		 4qvnH-5t0hO:
56.17
4qvnN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.94A 4qvnV-5t0hO:
29.8
4qvnW-5t0hO:
26.3		 4qvnV-5t0hO:
56.17
4qvnW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVP_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.96A 4qvpV-5t0hO:
29.8
4qvpb-5t0hO:
27.6		 4qvpV-5t0hO:
56.17
4qvpb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVP_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.96A 4qvpH-5t0hO:
28.7
4qvpI-5t0hO:
26.2		 4qvpH-5t0hO:
56.17
4qvpI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVP_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.96A 4qvpH-5t0hO:
28.7
4qvpN-5t0hO:
27.6		 4qvpH-5t0hO:
56.17
4qvpN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVP_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 4qvpV-5t0hO:
28.6
4qvpW-5t0hO:
26.2		 4qvpV-5t0hO:
56.17
4qvpW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVQ_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qvqV-5t0hO:
30.0
4qvqb-5t0hO:
27.6		 4qvqV-5t0hO:
56.17
4qvqb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVQ_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.96A 4qvqH-5t0hO:
28.8
4qvqI-5t0hO:
26.2		 4qvqH-5t0hO:
56.17
4qvqI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVQ_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qvqH-5t0hO:
28.8
4qvqN-5t0hO:
27.6		 4qvqH-5t0hO:
56.17
4qvqN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVQ_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 4qvqV-5t0hO:
30.0
4qvqW-5t0hO:
26.3		 4qvqV-5t0hO:
56.17
4qvqW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVV_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.94A 4qvvH-5t0hO:
28.9		 4qvvH-5t0hO:
56.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVV_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.94A 4qvvV-5t0hO:
30.1		 4qvvV-5t0hO:
56.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVW_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 1.00A 4qvwV-5t0hO:
29.9
4qvwb-5t0hO:
27.6		 4qvwV-5t0hO:
56.17
4qvwb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVW_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 1.03A 4qvwH-5t0hO:
28.8
4qvwI-5t0hO:
26.2		 4qvwH-5t0hO:
56.17
4qvwI-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 ALA O 134
ALA O 133
GLY O 128
ASP O 166
SER O 169
 None
 1.04A 4qvwK-5t0hO:
27.4
4qvwL-5t0hO:
24.3		 4qvwK-5t0hO:
28.27
4qvwL-5t0hO:
23.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVW_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 1.01A 4qvwH-5t0hO:
28.8
4qvwN-5t0hO:
27.6		 4qvwH-5t0hO:
56.17
4qvwN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVW_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 1.02A 4qvwV-5t0hO:
29.9
4qvwW-5t0hO:
26.2		 4qvwV-5t0hO:
56.17
4qvwW-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVW_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 ALA O 134
ALA O 133
GLY O 128
ASP O 166
SER O 169
 None
 1.05A 4qvwY-5t0hO:
20.8
4qvwZ-5t0hO:
24.1		 4qvwY-5t0hO:
28.27
4qvwZ-5t0hO:
23.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVY_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.97A 4qvyH-5t0hO:
28.8		 4qvyH-5t0hO:
56.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QVY_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.98A 4qvyV-5t0hO:
30.0
4qvyW-5t0hO:
26.2		 4qvyV-5t0hO:
56.17
4qvyW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW0_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 4qw0V-5t0hO:
30.1
4qw0b-5t0hO:
27.7		 4qw0V-5t0hO:
56.17
4qw0b-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW0_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.92A 4qw0H-5t0hO:
28.9
4qw0I-5t0hO:
26.2		 4qw0H-5t0hO:
56.17
4qw0I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW0_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 4qw0H-5t0hO:
28.9
4qw0N-5t0hO:
27.7		 4qw0H-5t0hO:
56.17
4qw0N-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW0_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.91A 4qw0V-5t0hO:
30.1
4qw0W-5t0hO:
26.2		 4qw0V-5t0hO:
56.17
4qw0W-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW1_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.96A 4qw1V-5t0hO:
29.8
4qw1b-5t0hO:
27.7		 4qw1V-5t0hO:
56.17
4qw1b-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW1_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.97A 4qw1H-5t0hO:
28.7
4qw1I-5t0hO:
26.2		 4qw1H-5t0hO:
56.17
4qw1I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW1_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qw1H-5t0hO:
28.7
4qw1N-5t0hO:
27.6		 4qw1H-5t0hO:
56.17
4qw1N-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW1_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.98A 4qw1V-5t0hO:
29.8
4qw1W-5t0hO:
26.2		 4qw1V-5t0hO:
56.17
4qw1W-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW3_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 4qw3V-5t0hO:
30.1
4qw3b-5t0hO:
27.7		 4qw3V-5t0hO:
56.17
4qw3b-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW3_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 0.98A 4qw3H-5t0hO:
29.0
4qw3I-5t0hO:
26.1		 4qw3H-5t0hO:
56.17
4qw3I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW3_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 4qw3H-5t0hO:
29.0
4qw3N-5t0hO:
27.7		 4qw3H-5t0hO:
56.17
4qw3N-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QW3_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 1.02A 4qw3V-5t0hO:
30.1
4qw3W-5t0hO:
26.1		 4qw3V-5t0hO:
56.17
4qw3W-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QWU_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 4qwuV-5t0hO:
29.6
4qwub-5t0hO:
27.5		 4qwuV-5t0hO:
56.17
4qwub-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QWU_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 1.02A 4qwuH-5t0hO:
28.5
4qwuI-5t0hO:
26.1		 4qwuH-5t0hO:
56.17
4qwuI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QWU_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 4qwuH-5t0hO:
28.5
4qwuN-5t0hO:
27.5		 4qwuH-5t0hO:
56.17
4qwuN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QWU_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 1.01A 4qwuV-5t0hO:
29.6
4qwuW-5t0hO:
26.2		 4qwuV-5t0hO:
56.17
4qwuW-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QZU_C_ACTC202_0
(RETINOL-BINDING
PROTEIN 2)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		4 / 6 TYR f 660
GLU f 677
THR f 673
LEU f 612
 None
 1.38A 4qzuC-5t0hf:
undetectable		 4qzuC-5t0hf:
10.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5BXN_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.97A 5bxnV-5t0hO:
29.8
5bxnb-5t0hO:
27.6		 5bxnV-5t0hO:
55.74
5bxnb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5BXN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.94A 5bxnH-5t0hO:
29.6
5bxnI-5t0hO:
26.3		 5bxnH-5t0hO:
55.74
5bxnI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5BXN_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.96A 5bxnH-5t0hO:
29.6
5bxnN-5t0hO:
27.5		 5bxnH-5t0hO:
55.74
5bxnN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5BXN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
 None
 0.82A 5bxnV-5t0hO:
29.8
5bxnW-5t0hO:
26.3		 5bxnV-5t0hO:
55.74
5bxnW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CZ7_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 1.02A 5cz7H-5t0hO:
28.8
5cz7I-5t0hO:
26.2		 5cz7H-5t0hO:
56.17
5cz7I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CZ7_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 5cz7H-5t0hO:
28.8
5cz7N-5t0hO:
27.7		 5cz7H-5t0hO:
56.17
5cz7N-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CZ7_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 5cz7V-5t0hO:
30.0
5cz7W-5t0hO:
26.2		 5cz7V-5t0hO:
56.17
5cz7W-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5D0X_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 5d0xV-5t0hO:
30.1
5d0xb-5t0hO:
27.7		 5d0xV-5t0hO:
56.17
5d0xb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5D0X_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
THR O  48
ALA O  49
THR O  52
 None
 1.02A 5d0xH-5t0hO:
28.9
5d0xI-5t0hO:
26.2		 5d0xH-5t0hO:
56.17
5d0xI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5D0X_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.95A 5d0xH-5t0hO:
28.9
5d0xN-5t0hO:
27.7		 5d0xH-5t0hO:
56.17
5d0xN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5D0X_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.97A 5d0xV-5t0hO:
30.1		 5d0xV-5t0hO:
56.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB603_1
(PHIAB6 TAILSPIKE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		3 / 3 VAL f 450
GLU f 422
GLU f 465
 None
 0.73A 5jsdB-5t0hf:
undetectable
5jsdC-5t0hf:
undetectable		 5jsdB-5t0hf:
22.00
5jsdC-5t0hf:
22.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5F_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 5l5fH-5t0hO:
28.8
5l5fI-5t0hO:
26.3		 5l5fH-5t0hO:
56.17
5l5fI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5F_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 5l5fV-5t0hO:
30.0
5l5fW-5t0hO:
26.3		 5l5fV-5t0hO:
56.17
5l5fW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.94A 5l5zV-5t0hO:
30.0
5l5zb-5t0hO:
27.6		 5l5zV-5t0hO:
56.17
5l5zb-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 1.00A 5l5zH-5t0hO:
28.8
5l5zI-5t0hO:
17.3		 5l5zH-5t0hO:
56.17
5l5zI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O  55
GLN O  57
ALA O  46
GLY O  45
ALA O  49
 None
 1.16A 5l5zH-5t0hO:
28.8
5l5zI-5t0hO:
17.3		 5l5zH-5t0hO:
56.17
5l5zI-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.95A 5l5zH-5t0hO:
28.8
5l5zN-5t0hO:
27.7		 5l5zH-5t0hO:
56.17
5l5zN-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		7 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 5l5zV-5t0hO:
28.8
5l5zW-5t0hO:
26.3		 5l5zV-5t0hO:
56.17
5l5zW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L5Z_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O  55
GLN O  57
ALA O  46
GLY O  45
ALA O  49
 None
 1.14A 5l5zV-5t0hO:
28.8
5l5zW-5t0hO:
26.3		 5l5zV-5t0hO:
56.17
5l5zW-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L66_B_BO2B201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.94A 5l66V-5t0hO:
30.0
5l66b-5t0hO:
27.6		 5l66V-5t0hO:
56.17
5l66b-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L66_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.96A 5l66H-5t0hO:
28.8
5l66I-5t0hO:
26.4		 5l66H-5t0hO:
56.17
5l66I-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L66_N_BO2N201_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-1)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 11 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.95A 5l66H-5t0hO:
28.8
5l66N-5t0hO:
27.6		 5l66H-5t0hO:
56.17
5l66N-5t0hO:
30.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5L66_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.97A 5l66V-5t0hO:
30.0
5l66W-5t0hO:
26.3		 5l66V-5t0hO:
56.17
5l66W-5t0hO:
20.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_H_BO2H306_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 10 ALA O  20
CYH O  31
ALA O  46
GLY O  47
ALA O  49
 None
 0.75A 5lf3H-5t0hO:
30.9
5lf3I-5t0hO:
26.1		 5lf3H-5t0hO:
100.00
5lf3I-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_H_BO2H306_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 10 THR O   1
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 5lf3H-5t0hO:
30.9
5lf3I-5t0hO:
26.1		 5lf3H-5t0hO:
100.00
5lf3I-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_H_BO2H306_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 10 THR O   1
CYH O  31
ALA O  46
GLY O  47
ALA O  49
 None
 0.77A 5lf3H-5t0hO:
30.9
5lf3I-5t0hO:
26.1		 5lf3H-5t0hO:
100.00
5lf3I-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_V_BO2V303_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 10 ALA O  20
LYS O  33
ALA O  46
GLY O  47
ALA O  49
 None
 0.85A 5lf3V-5t0hO:
30.9
5lf3W-5t0hO:
26.2		 5lf3V-5t0hO:
100.00
5lf3W-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF3_V_BO2V303_1
(PROTEASOME SUBUNIT
BETA TYPE-7
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 10 THR O   1
LYS O  33
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 1.04A 5lf3V-5t0hO:
30.9
5lf3W-5t0hO:
26.2		 5lf3V-5t0hO:
100.00
5lf3W-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_B_6V8B304_0
(PROTEASOME SUBUNIT
BETA TYPE-6
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 5lf7V-5t0hO:
31.0
5lf7b-5t0hO:
27.2		 5lf7V-5t0hO:
100.00
5lf7b-5t0hO:
27.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_H_6V8H305_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 ALA O  20
CYH O  31
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.96A 5lf7H-5t0hO:
30.9
5lf7I-5t0hO:
26.1		 5lf7H-5t0hO:
100.00
5lf7I-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_H_6V8H305_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
CYH O  31
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.99A 5lf7H-5t0hO:
30.9
5lf7I-5t0hO:
26.1		 5lf7H-5t0hO:
100.00
5lf7I-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_N_6V8N305_0
(PROTEASOME SUBUNIT
BETA TYPE-6
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 1.01A 5lf7H-5t0hO:
30.9
5lf7N-5t0hO:
27.2		 5lf7H-5t0hO:
100.00
5lf7N-5t0hO:
27.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_V_6V8V303_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 ALA O  20
CYH O  31
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.95A 5lf7V-5t0hO:
31.0
5lf7W-5t0hO:
26.2		 5lf7V-5t0hO:
100.00
5lf7W-5t0hO:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5LF7_V_6V8V303_0
(PROTEASOME SUBUNIT
BETA TYPE-3
PROTEASOME SUBUNIT
BETA TYPE-7)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		6 / 11 THR O   1
CYH O  31
ALA O  46
GLY O  47
ALA O  49
THR O  52
 None
 0.98A 5lf7V-5t0hO:
31.0
5lf7W-5t0hO:
26.2		 5lf7V-5t0hO:
100.00
5lf7W-5t0hO:
22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_B_ZITB501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 ILE O  34
VAL O 177
PHE O 138
ALA O 134
GLY O 130
 None
 1.10A 5uxdB-5t0hO:
undetectable		 5uxdB-5t0hO:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6E8Q_A_X2NA602_0
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 12 GLY f 369
ILE f 651
GLY f 321
LEU f 328
MET f 365
 None
 1.21A 6e8qA-5t0hf:
undetectable		 6e8qA-5t0hf:
8.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FDY_U_DB8U302_1
(-)		 5t0h 26S PROTEASOME
NON-ATPASE
REGULATORY SUBUNIT 2
(Homo
sapiens) 		5 / 9 LEU f 513
PHE f 554
SER f 552
LEU f 551
ILE f 547
 None
 1.04A 6fdyU-5t0hf:
undetectable		 6fdyU-5t0hf:
16.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6HWD_B_BO2B201_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 1.01A 6hwdV-5t0hO:
29.9
6hwdb-5t0hO:
27.5		 6hwdV-5t0hO:
47.27
6hwdb-5t0hO:
15.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6HWD_H_BO2H301_0
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 12 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.95A 6hwdH-5t0hO:
28.8
6hwdI-5t0hO:
26.2		 6hwdH-5t0hO:
47.27
6hwdI-5t0hO:
17.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6HWD_N_BO2N201_0
(PROTEASOME SUBUNIT
BETA TYPE-1
PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		5 / 12 THR O   1
LYS O  33
GLY O  47
ALA O  49
THR O  52
 None
 1.01A 6hwdH-5t0hO:
28.8
6hwdN-5t0hO:
27.5		 6hwdH-5t0hO:
47.27
6hwdN-5t0hO:
15.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6HWD_V_BO2V301_0
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5t0h PROTEASOME SUBUNIT
BETA TYPE-7
(Homo
sapiens) 		8 / 11 THR O   1
CYH O  31
LYS O  33
ALA O  46
GLY O  47
THR O  48
ALA O  49
THR O  52
 None
 0.96A 6hwdV-5t0hO:
29.9		 6hwdV-5t0hO:
47.27